Chronic illness and disability costs crippling some Australians News item 08 February 2013 Pages: 2 - 2
“Catastrophic“ medical costs for diabetics in low-income countries Clinical study 08 February 2013 Pages: 3 - 3
Fully-funded influenza vaccination of elderly worth it in Poland Clinical study 08 February 2013 Pages: 3 - 3
Rivaroxaban better than enoxaparin for post-surgical VTE Clinical study 08 February 2013 Pages: 3 - 3
Best TB diagnostic strategy for patients initiating ART? Clinical study 08 February 2013 Pages: 4 - 4
Both primary and booster coverage affected by US Hib vax shortage Clinical study 08 February 2013 Pages: 4 - 4
Costs of treating chronic hep B vary according to guideline used Clinical study 08 February 2013 Pages: 5 - 5
Could broad-spectrum HPV vax reduce the need for screening? Clinical study 08 February 2013 Pages: 5 - 5
First-line FOLFIRINOX “attractive cost-effective treatment“ for mPC Clinical study 08 February 2013 Pages: 6 - 6
Maintenance pemetrexed not cost effective in Switzerland Clinical study 08 February 2013 Pages: 6 - 6
Non-formulary PPI use uncommon but costly in VA population Clinical study 08 February 2013 Pages: 6 - 6
Pneumonia a “substantial burden“ to Australian health system Clinical study 08 February 2013 Pages: 6 - 6
Routine PCV-10 vaccination best choice for Colombian children Clinical study 08 February 2013 Pages: 7 - 7
Semi-annual surveillance for HCC cost effective in cirrhotic patients? Clinical study 08 February 2013 Pages: 7 - 7
Which cervical cancer screening interval and test is best? Clinical study 08 February 2013 Pages: 7 - 7
Effect of increased reimbursement on adolescent vaccine uptake Clinical study 08 February 2013 Pages: 8 - 8
Risk-adaptive use of plerixafor effective and saves costs Clinical study 08 February 2013 Pages: 9 - 9
Self-monitoring blood glucose costs high for T1DM patients Clinical study 08 February 2013 Pages: 9 - 9
Treating hypertension is highly cost effective in Greece Clinical study 08 February 2013 Pages: 9 - 9
Ireland could cut branded drug prices substantially, says report Media release 08 February 2013 Pages: 10 - 10
Neoadjuvant CRT prior to surgery cost effective for pancreatic cancer Clinical study 08 February 2013 Pages: 10 - 10
Poorer tolerance and higher costs after switch to capecitabine Clinical study 08 February 2013 Pages: 10 - 10
Eribulin now available under national reimbursement in Italy Media release 08 February 2013 Pages: 11 - 11
European coronary stent market to shrink to $US490 million Media release 08 February 2013 Pages: 11 - 11